< Back


Third-Party Reimbursement of Phase III Clinical Trials

RESOLVED, That the North Carolina Medical Society supports health insurance coverage for services provided in conjunction with Phase III trials sanctioned by the National Cancer Institute or Institute of Medicine, for all cancers and for life-threatening, degenerative, permanently disabling conditions.

(Report M-2000, adopted 11/12/00)
(revised, Report R-2006, Item 58, adopted 10/29/2006)
(reaffirmed, Reaffirmation Report-2013, Item 15, adopted 10/26/2013)
(reaffirmed, Board Report-2018, Item 196, adopted 11/3/2018)